Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-05-14
1995-01-10
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3120
Patent
active
053807570
ABSTRACT:
Gamma-linolenic (GLA) and/or dihomo-gamma-linolenic acid (DGLA) may be used in the treatment of vulvar dystrophy and/or vaginal dryness. Other essential fatty acids of the n-6 or n-3 series may also be used in association with GLA and/or DGLA.
REFERENCES:
patent: 4681896 (1987-07-01), Horrobin
patent: 5059622 (1991-10-01), Sears
patent: 5145686 (1992-09-01), Horrobin et al.
Robinson; Can. Med. Assoc. J., vol. 140, No. 6, 1989; "Premenstrual Syndrome: Current Knowledge and Management"; pp. 605-611.
Bonacossa et al.; Prostaglandins, vol. 23, No. 1, 1982; "Effect of Corticosterone . . . "; pp. 113-128.
Ney; Med. Hypotheses, vol. 20, No. 2, Jun. 1986; "The Intravaginal Absorption of Male Generated Hormones and Their Possible Effect on Female Behaviour"; Abstract.
European Search Report, Sep. 1993.
Cintins Marianne M.
Jordan Kimberly R.
Scotia Holdings PLC
LandOfFree
Method of treating vulvar dystrophy and vaginal dryness does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating vulvar dystrophy and vaginal dryness, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating vulvar dystrophy and vaginal dryness will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850970